Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study.

Fousekis FS, Katsanos KH, Theopistos VI, Baltayiannis G, Kosmidou M, Glantzounis G, Christou L, Tsianos EV, Christodoulou DK.

BMC Gastroenterol. 2019 Apr 3;19(1):48. doi: 10.1186/s12876-019-0967-3.

2.

Perioperative Use of Anti-TNFa Biological Agents in Open and Laparoscopic Surgery for Inflammatory Bowel Disease.

Lianos GD, Katsanos KH, Saridi M, Albani E, Koutroumpakis E, Zeglinas C, Glantzounis GK, Papaconstantinou I, Christodoulou DK.

Surg Technol Int. 2019 May 15;34:107-114.

PMID:
30888671
3.

Presence of pseudopolyps in ulcerative colitis is associated with a higher risk for treatment escalation.

Politis DS, Papamichael K, Katsanos KH, Koulouridis I, Mavromati D, Tsianos EV, Christodoulou DK.

Ann Gastroenterol. 2019 Mar-Apr;32(2):168-173. doi: 10.20524/aog.2019.0357. Epub 2019 Jan 23. Review.

4.

The Developing Story of Predictive Biomarkers in Colorectal Cancer.

Boussios S, Ozturk MA, Moschetta M, Karathanasi A, Zakynthinakis-Kyriakou N, Katsanos KH, Christodoulou DK, Pavlidis N.

J Pers Med. 2019 Feb 7;9(1). pii: E12. doi: 10.3390/jpm9010012. Review.

5.

Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.

Fousekis FS, Theopistos VI, Mitselos IV, Skamnelos A, Kavvadias A, Katsanos KH, Christodoulou DK.

J Clin Med Res. 2019 Feb;11(2):81-88. doi: 10.14740/jocmr3680. Epub 2019 Jan 5. Review.

6.

Selecting mixtures on the basis of dietary exposure and hazard data: application to pesticide exposure in the European population in relation to steatosis.

Crépet A, Vanacker M, Sprong C, de Boer W, Blaznik U, Kennedy M, Anagnostopoulos C, Christodoulou DL, Ruprich J, Rehurkova I, Domingo JL, Hamborg Jensen B, Metruccio F, Moretto A, Jacxsens L, Spanoghe P, Senaeve D, van der Voet H, van Klaveren J.

Int J Hyg Environ Health. 2019 Mar;222(2):291-306. doi: 10.1016/j.ijheh.2018.12.002. Epub 2018 Dec 20.

PMID:
30579770
7.

Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD study.

Burisch J, Zammit SC, Ellul P, Turcan S, Duricova D, Bortlik M, Andersen KW, Andersen V, Kaimakliotis IP, Fumery M, Gower-Rousseau C, Girardin G, Valpiani D, Goldis A, Brinar M, Čuković-Čavka S, Oksanen P, Collin P, Barros L, Magro F, Misra R, Arebi N, Eriksson C, Halfvarson J, Kievit HAL, Pedersen N, Kjeldsen J, Myers S, Sebastian S, Katsanos KH, Christodoulou DK, Midjord J, Nielsen KR, Kiudelis G, Kupcinskas L, Nikulina I, Belousova E, Schwartz D, Odes S, Salupere R, Carmona A, Pineda JR, Vegh Z, Lakatos PL, Langholz E, Munkholm P; Epi-IBD group.

J Gastroenterol Hepatol. 2019 Jun;34(6):996-1003. doi: 10.1111/jgh.14563. Epub 2019 Jan 21.

PMID:
30562421
8.

Inflammatory Bowel Disease [IBD] and Physical Activity: A Study on the Impact of Diagnosis on the Level of Exercise Amongst Patients With IBD.

Gatt K, Schembri J, Katsanos KH, Christodoulou D, Karmiris K, Kopylov U, Pontas C, Koutroubakis IE, Foteinogiannopoulou K, Fabian A, Molnar T, Zammit D, Fragaki M, Balomenos D, Zingboim N, Ben Horin S, Mantzaris GJ, Ellul P.

J Crohns Colitis. 2019 May 27;13(6):686-692. doi: 10.1093/ecco-jcc/jjy214.

PMID:
30561568
9.

A multicentre Study of Nutrition Risk Assessment in Adult Patients with Inflammatory Bowel Disease Attending Outpatient Clinics.

Lomer MCE, Cahill O, Baschali A, Partha Sarathy P, Sarantidou M, Mantzaris GJ, Gaya DR, Katsanos K, Christodoulou DK, Gerasimidis K.

Ann Nutr Metab. 2019;74(1):18-23. doi: 10.1159/000495214. Epub 2018 Nov 28.

PMID:
30485836
10.

Malignant peritoneal mesothelioma: clinical aspects, and therapeutic perspectives.

Boussios S, Moschetta M, Karathanasi A, Tsiouris AK, Kanellos FS, Tatsi K, Katsanos KH, Christodoulou DK.

Ann Gastroenterol. 2018 Nov-Dec;31(6):659-669. doi: 10.20524/aog.2018.0305. Epub 2018 Sep 14. Review.

11.

Alcohol and narcotics use in inflammatory bowel disease.

Mantzouranis G, Fafliora E, Saridi M, Tatsioni A, Glanztounis G, Albani E, Katsanos KH, Christodoulou DK.

Ann Gastroenterol. 2018 Nov-Dec;31(6):649-658. doi: 10.20524/aog.2018.0302. Epub 2018 Aug 1. Review.

12.

Vitamin D and Ulcerative Colitis: Is There a Relationship with Disease Extent?

Chetcuti Zammit S, Schembri J, Pisani A, Vella S, Azzopardi M, Skamnelos A, Christodoulou DK, Katsanos KH, Ellul P.

Dig Dis. 2019;37(3):208-213. doi: 10.1159/000494439. Epub 2018 Nov 1.

PMID:
30384373
13.

Dermal Lesions and Skin Cancer in Patients with Inflammatory Bowel Disease Receiving Immunosuppressive Therapy

Giagkou E, Saridi M, Albani E, Gaitanis G, Katsanos A, Bechlioulis A, Bacasis AD, Christodoulou DK, Katsanos KH.

Asian Pac J Cancer Prev. 2018 Oct 26;19(10):2845-2851.

14.

Sexual Dysfunction in Patients With Inflammatory Bowel Disease.

Katsanos KH, Saridi M, Albani E, Mantzouranis G, Zmora O, Christodoulou DK.

Inflamm Bowel Dis. 2018 Oct 12;24(11):2348-2349. doi: 10.1093/ibd/izy206. No abstract available.

PMID:
30312432
15.

Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD Study.

Burisch J, Katsanos KH, Christodoulou DK, Barros L, Magro F, Pedersen N, Kjeldsen J, Vegh Z, Lakatos PL, Eriksson C, Halfvarson J, Fumery M, Gower-Rousseau C, Brinar M, Cukovic-Cavka S, Nikulina I, Belousova E, Myers S, Sebastian S, Kiudelis G, Kupcinskas L, Schwartz D, Odes S, Kaimakliotis IP, Valpiani D, D'Incà R, Salupere R, Chetcuti Zammit S, Ellul P, Duricova D, Bortlik M, Goldis A, Kievit HAL, Toca A, Turcan S, Midjord J, Nielsen KR, Andersen KW, Andersen V, Misra R, Arebi N, Oksanen P, Collin P, de Castro L, Hernandez V, Langholz E, Munkholm P; Epi-IBD Group.

J Crohns Colitis. 2019 Feb 1;13(2):198-208. doi: 10.1093/ecco-jcc/jjy154.

PMID:
30289522
16.

The role of multimodal treatment in Crohn's disease patients with perianal fistula: a multicentre retrospective cohort study.

Sebastian S, Black C, Pugliese D, Armuzzi A, Sahnan K, Elkady SM, Katsanos KH, Christodoulou DK, Selinger C, Maconi G, Fearnhead NS, Kopylov U, Davidov Y, Bosca-Watts MM, Ellul P, Muscat M, Karmiris K, Hart AL, Danese S, Ben-Horin S, Fiorino G.

Aliment Pharmacol Ther. 2018 Nov;48(9):941-950. doi: 10.1111/apt.14969. Epub 2018 Sep 18.

PMID:
30226271
17.

Pancreatic Involvement in Inflammatory Bowel Disease: A Review.

Fousekis FS, Theopistos VI, Katsanos KH, Christodoulou DK.

J Clin Med Res. 2018 Oct;10(10):743-751. doi: 10.14740/jocmr3561w. Epub 2018 Sep 10. Review.

18.

Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study.

Chetcuti Zammit S, Ellul P, Girardin G, Valpiani D, Nielsen KR, Olsen J, Goldis A, Lazar D, Shonová O, Nováková M, Sebastian S, Whitehead E, Carmona A, Martinez-Cadilla J, Dahlerup JF, Kievit ALH, Thorsgaard N, Katsanos KH, Christodoulou DK, Magro F, Salupere R, Pedersen N, Kjeldsen J, Carlsen K, Ioannis K, Bergemalm D, Halfvarson J, Duricova D, Bortlik M, Collin P, Oksanen P, Kiudelis G, Kupcinskas L, Kudsk K, Andersen V, O'Morain C, Bailey Y, Doron S, Shmuel O, Almer S, Arebi N, Misra R, Čuković-Čavka S, Brinar M, Munkholm P, Vegh Z, Burisch J.

Eur J Gastroenterol Hepatol. 2018 Nov;30(11):1297-1303. doi: 10.1097/MEG.0000000000001238.

PMID:
30134383
19.

What defines quality in small bowel capsule endoscopy.

Mitselos IV, Christodoulou DK.

Ann Transl Med. 2018 Jul;6(13):260. doi: 10.21037/atm.2018.05.28. Review.

20.

Capacity for instantaneous catabolism of preferred and non-preferred carbon sources in Escherichia coli and Bacillus subtilis.

Buffing MF, Link H, Christodoulou D, Sauer U.

Sci Rep. 2018 Aug 6;8(1):11760. doi: 10.1038/s41598-018-30266-3.

21.

Glucose promotes cell growth by suppressing branched-chain amino acid degradation.

Shao D, Villet O, Zhang Z, Choi SW, Yan J, Ritterhoff J, Gu H, Djukovic D, Christodoulou D, Kolwicz SC Jr, Raftery D, Tian R.

Nat Commun. 2018 Jul 26;9(1):2935. doi: 10.1038/s41467-018-05362-7.

22.

Ear Involvement in Inflammatory Bowel Disease: A Review of the Literature.

Fousekis FS, Saridi M, Albani E, Daniel F, Katsanos KH, Kastanioudakis IG, Christodoulou DK.

J Clin Med Res. 2018 Aug;10(8):609-614. doi: 10.14740/jocmr3465w. Epub 2018 Jun 27. Review.

23.

A new minimally invasive treatment of pilonidal sinus disease with the use of a diode laser: a prospective large series of patients.

Pappas AF, Christodoulou DK.

Colorectal Dis. 2018 Aug;20(8):O207-O214. doi: 10.1111/codi.14285. Epub 2018 Jun 27.

PMID:
29878584
24.

Dynamic Cellular Integration Drives Functional Assembly of the Heart's Pacemaker Complex.

Bressan M, Henley T, Louie JD, Liu G, Christodoulou D, Bai X, Taylor J, Seidman CE, Seidman JG, Mikawa T.

Cell Rep. 2018 May 22;23(8):2283-2291. doi: 10.1016/j.celrep.2018.04.075.

25.

Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study.

Kopylov U, Verstockt B, Biedermann L, Sebastian S, Pugliese D, Sonnenberg E, Steinhagen P, Arebi N, Ron Y, Kucharzik T, Roblin X, Ungar B, Shitrit AB, Ardizzone S, Molander P, Coletta M, Peyrin-Biroulet L, Bossuyt P, Avni-Biron I, Tsoukali E, Allocca M, Katsanos K, Raine T, Sipponen T, Fiorino G, Ben-Horin S, Eliakim R, Armuzzi A, Siegmund B, Baumgart DC, Kamperidis N, Maharshak N, Maaser C, Mantzaris G, Yanai H, Christodoulou DK, Dotan I, Ferrante M.

Inflamm Bowel Dis. 2018 Oct 12;24(11):2442-2451. doi: 10.1093/ibd/izy155.

PMID:
29788318
26.

Reserve Flux Capacity in the Pentose Phosphate Pathway Enables Escherichia coli's Rapid Response to Oxidative Stress.

Christodoulou D, Link H, Fuhrer T, Kochanowski K, Gerosa L, Sauer U.

Cell Syst. 2018 May 23;6(5):569-578.e7. doi: 10.1016/j.cels.2018.04.009. Epub 2018 May 9.

27.

Role of bile acids in inflammatory bowel disease.

Tiratterra E, Franco P, Porru E, Katsanos KH, Christodoulou DK, Roda G.

Ann Gastroenterol. 2018 May-Jun;31(3):266-272. doi: 10.20524/aog.2018.0239. Epub 2018 Feb 14. Review.

28.

Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel Disease.

Katsanos KH, Kyriakidi K, Skamnelos A, Christodoulou DK.

Inflamm Bowel Dis. 2018 May 18;24(6):1272-1273. doi: 10.1093/ibd/izy089. No abstract available.

PMID:
29718259
29.

Clinical Use of Patency Capsule: A Comprehensive Review of the Literature.

Mitselos IV, Katsanos K, Tsianos EV, Eliakim R, Christodoulou D.

Inflamm Bowel Dis. 2018 Oct 12;24(11):2339-2347. doi: 10.1093/ibd/izy152.

PMID:
29718225
30.

Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.

Fousekis FS, Theopistos VI, Katsanos KH, Tsianos EV, Christodoulou DK.

Gastroenterology Res. 2018 Apr;11(2):83-94. doi: 10.14740/gr990w. Epub 2018 Apr 7. Review.

31.

Association of clinical and inflammatory markers with small bowel capsule endoscopy findings in Crohn's disease.

Mitselos IV, Katsanos KH, Tatsioni A, Skamnelos A, Eliakim R, Tsianos EV, Christodoulou DK.

Eur J Gastroenterol Hepatol. 2018 Aug;30(8):861-867. doi: 10.1097/MEG.0000000000001146.

PMID:
29697457
32.

Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapies.

Katsanos KH, Papamichael K, Feuerstein JD, Christodoulou DK, Cheifetz AS.

Clin Immunol. 2018 Mar 12. pii: S1521-6616(17)30901-4. doi: 10.1016/j.clim.2018.03.004. [Epub ahead of print]

PMID:
29545207
33.

Time-driven activity-based cost comparison of prostate cancer brachytherapy and intensity-modulated radiation therapy.

Dutta SW, Bauer-Nilsen K, Sanders JC, Trifiletti DM, Libby B, Lash DH, Lain M, Christodoulou D, Hodge C, Showalter TN.

Brachytherapy. 2018 May - Jun;17(3):556-563. doi: 10.1016/j.brachy.2018.01.013. Epub 2018 Mar 5.

PMID:
29519605
34.

Full Interchangeability in Regards to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease.

Katsanos KH, Papamichael K, Cheifetz AS, Christodoulou DK.

Inflamm Bowel Dis. 2018 Feb 15;24(3):465-466. doi: 10.1093/ibd/izx092. No abstract available.

PMID:
29462402
35.

Systemic hemodynamic response to terlipressin predicts development of hepatorenal syndrome and survival in advanced cirrhosis.

Kalambokis GN, Tsiakas I, Christaki M, Koustousi C, Christou L, Baltayiannis G, Christodoulou D.

Eur J Gastroenterol Hepatol. 2018 Jun;30(6):659-667. doi: 10.1097/MEG.0000000000001088.

PMID:
29432366
36.

Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study.

Burisch J, Kiudelis G, Kupcinskas L, Kievit HAL, Andersen KW, Andersen V, Salupere R, Pedersen N, Kjeldsen J, D'Incà R, Valpiani D, Schwartz D, Odes S, Olsen J, Nielsen KR, Vegh Z, Lakatos PL, Toca A, Turcan S, Katsanos KH, Christodoulou DK, Fumery M, Gower-Rousseau C, Chetcuti Zammit S, Ellul P, Eriksson C, Halfvarson J, Magro FJ, Duricova D, Bortlik M, Fernandez A, Hernández V, Myers S, Sebastian S, Oksanen P, Collin P, Goldis A, Misra R, Arebi N, Kaimakliotis IP, Nikuina I, Belousova E, Brinar M, Cukovic-Cavka S, Langholz E, Munkholm P; Epi-IBD group.

Gut. 2018 Jan 23. pii: gutjnl-2017-315568. doi: 10.1136/gutjnl-2017-315568. [Epub ahead of print]

PMID:
29363534
37.

Cardiac-enriched BAF chromatin-remodeling complex subunit Baf60c regulates gene expression programs essential for heart development and function.

Sun X, Hota SK, Zhou YQ, Novak S, Miguel-Perez D, Christodoulou D, Seidman CE, Seidman JG, Gregorio CC, Henkelman RM, Rossant J, Bruneau BG.

Biol Open. 2018 Jan 5;7(1). pii: bio029512. doi: 10.1242/bio.029512.

38.

Current and future biomarkers in colorectal cancer.

Zarkavelis G, Boussios S, Papadaki A, Katsanos KH, Christodoulou DK, Pentheroudakis G.

Ann Gastroenterol. 2017;30(6):613-621. doi: 10.20524/aog.2017.0191. Epub 2017 Sep 22. Review.

39.

Terlipressin is superior to midodrine/octreotide for hepatorenal syndrome type 1.

Kalambokis GN, Baltayiannis G, Christodoulou D, Christou L.

Eur J Gastroenterol Hepatol. 2017 Dec;29(12):1428-1429. doi: 10.1097/MEG.0000000000000988. No abstract available.

PMID:
29111999
40.

Evaluation of Delivery Costs for External Beam Radiation Therapy and Brachytherapy for Locally Advanced Cervical Cancer Using Time-Driven Activity-Based Costing.

Bauer-Nilsen K, Hill C, Trifiletti DM, Libby B, Lash DH, Lain M, Christodoulou D, Hodge C, Showalter TN.

Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):88-94. doi: 10.1016/j.ijrobp.2017.09.004. Epub 2017 Sep 14.

PMID:
29079120
41.

Haemostatic balance in patients with end-stage cirrhosis: low protein C is the predominant coagulant protein deficiency.

Kalambokis GN, Christou L, Christodoulou D, Baltayiannis G.

Blood Coagul Fibrinolysis. 2017 Oct;28(7):585-586. doi: 10.1097/MBC.0000000000000651. No abstract available.

PMID:
29019866
42.

Histological healing beyond endoscopic healing in ulcerative colitis: Shall we target the "ultra-deep" remission?

Katsanos KH, Papamichael K, Christodoulou DK, Cheifetz AS.

Dig Liver Dis. 2017 Dec;49(12):1332-1333. doi: 10.1016/j.dld.2017.08.043. Epub 2017 Sep 18. No abstract available.

PMID:
28964677
43.

Genome-Scale Architecture of Small Molecule Regulatory Networks and the Fundamental Trade-Off between Regulation and Enzymatic Activity.

Reznik E, Christodoulou D, Goldford JE, Briars E, Sauer U, Segrè D, Noor E.

Cell Rep. 2017 Sep 12;20(11):2666-2677. doi: 10.1016/j.celrep.2017.08.066.

44.

A novel minimally invasive treatment for anal fissure.

Pappas AF, Christodoulou DK.

Ann Gastroenterol. 2017;30(5):583. doi: 10.20524/aog.2017.0173. Epub 2017 Jun 30. No abstract available.

45.

Primary liver cancer genome sequencing: translational implications and challenges.

Ziogas DE, Kyrochristos ID, Glantzounis GK, Christodoulou D, Felekouras E, Roukos DH.

Expert Rev Gastroenterol Hepatol. 2017 Oct;11(10):875-883. doi: 10.1080/17474124.2017.1356227. Epub 2017 Jul 26.

PMID:
28712319
46.

Strongyloides stercoralis infection: an "exotic" cause of chronic diarrhea.

Politis DS, Triantafyllidi E, Katsanos KH, Christodoulou DK.

Ann Gastroenterol. 2017;30(4):467. doi: 10.20524/aog.2017.0160. Epub 2017 May 12. No abstract available.

47.

Experimental gastric endoscopic submucosal dissection: training in a porcine model.

Kasapidis P, Bassioukas S, Mavrogenis G, Tribonias G, Delis K, Georgopoulos S, Christodoulou D, Emmanouil T, Paraskeva K, Panteris V, Papalois A, Triantafillidis J, Tsiamoulos Z, Fukuhara T, Komeda Y, Kashida H.

Ann Gastroenterol. 2017;30(4):446-449. doi: 10.20524/aog.2017.0147. Epub 2017 Apr 12.

48.

Beta adrenergic blockade and advanced cirrhosis: Does it really improve survival in patients with acute-on-chronic liver failure?

Kalambokis GN, Baltayannis G, Christodoulou D, Christou L.

J Hepatol. 2017 Oct;67(4):878-880. doi: 10.1016/j.jhep.2017.02.038. Epub 2017 Jul 11. No abstract available.

PMID:
28600138
49.

Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study.

Kopylov U, Papamichael K, Katsanos K, Waterman M, Bar-Gil Shitrit A, Boysen T, Portela F, Peixoto A, Szilagyi A, Silva M, Maconi G, Har-Noy O, Bossuyt P, Mantzaris G, Barreiro de Acosta M, Chaparro M, Christodoulou DK, Eliakim R, Rahier JF, Magro F, Drobne D, Ferrante M, Sonnenberg E, Siegmund B, Muls V, Thurm T, Yanai H, Dotan I, Raine T, Levin A, Israeli E, Ghalim F, Carbonnel F, Vermeire S, Ben-Horin S, Roblin X.

Inflamm Bowel Dis. 2017 Sep;23(9):1605-1613. doi: 10.1097/MIB.0000000000001160.

PMID:
28590343
50.

Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort-An ECCO-EpiCom Study.

Burisch J, Vegh Z, Katsanos KH, Christodoulou DK, Lazar D, Goldis A, O'Morain C, Fernandez A, Pereira S, Myers S, Sebastian S, Pedersen N, Olse J, Rubek Nielsen K, Schwartz D, Odes S, Almer S, Halfvarson J, Turk N, Cukovic-Cavka S, Nikulina I, Belousova E, Duricova D, Bortlik M, Shonová O, Salupere R, Barros L, Magro F, Jonaitis L, Kupcinskas L, Turcan S, Kaimakliotis I, Ladefoged K, Kudsk K, Andersen V, Vind I, Thorsgaard N, Oksanen P, Collin P, Dal Piaz G, Santini A, Niewiadomski O, Bell S, Moum B, Arebi N, Kjeldsen J, Carlsen K, Langholz E, Lakatos PL, Munkholm P, Gerdes LU, Dahlerup JF; EpiCom study group.

J Crohns Colitis. 2017 Oct 1;11(10):1213-1222. doi: 10.1093/ecco-jcc/jjx077.

PMID:
28575481

Supplemental Content

Loading ...
Support Center